Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

We investigated whether serial measurements of circulating tumor DNA (ctDNA) and functional tumor volume (FTV) by magnetic resonance imaging (MRI) can be combined to improve prediction of pathologic complete response (pCR) and estimation of recurrence risk in early breast cancer patients treated wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:NPJ Breast Cancer
Asıl Yazarlar: Magbanua, Mark Jesus M., Li, Wen, Wolf, Denise M., Yau, Christina, Hirst, Gillian L., Swigart, Lamorna Brown, Newitt, David C., Gibbs, Jessica, Delson, Amy L., Kalashnikova, Ekaterina, Aleshin, Alexey, Zimmermann, Bernhard, Chien, A. Jo, Tripathy, Debu, Esserman, Laura, Hylton, Nola, van ‘t Veer, Laura
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994408/
https://ncbi.nlm.nih.gov/pubmed/33767190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-021-00239-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller